Harnessing the power of
Collective Wisdom
to transform
medical cannabis care

Medical cannabis has vast potential for transforming chronic patient care by alleviating symptoms, significantly improving quality of life, and reducing the use of other medications, such as opiates.

Despite thousands of years of documented medical cannabis use and a rapidly evolving evidence base, stakeholders, physicians and caregivers still lack the data needed to make real-world decisions for medical cannabis-based treatments.

Introducing ASAYA

Chronic patient treatment involving medical cannabis requires a unique methodology and a multidisciplinary approach.

Addressing

major

unmet

NEEDS

UNMET NEED

Limited knowledge
& clinical evidence

UNMET NEED
UNMET NEED

Lack of ongoing patient support and monitoring

UNMET NEED
UNMET NEED

Limited transparency of
active ingredients and their composition

UNMET NEED
RESULT

 – A challenging decision-making process for both clinicians
and patients

– Insufficient ability to realize the remarkable therapeutic potential
of medical cannabis, mainly for the treatment of chronic symptoms.

RESULT

A smart digital platform that enables physicians to confidently prescribe medical cannabis as a treatment, and improve chronic patients’ treatment outcomes

ASAYA OFFERS HCPs:

ASAYA OFFERS PATIENTS A PERSONAL, SMART TREATMENT COMPANION

Take an active role in the management of your medical cannabis regimen plan

MISSION Statement​

Our technological yet human platform helps improve medical cannabis patients’ quality of life by accompanying them throughout their cannabis journey, as well as by enabling physicians to provide them with the best possible treatment.

Israel, as a centerpiece of knowledge, allowed us to create a consortium of medical cannabis stakeholders that is continuously exchanging data and experience, providing valuable input to our unique big data platform of real-world evidence.
Amit Sade
Co-Founder, CEO
Harnessing our experience, talent and passion, we’ve embarked on a quest to turn patient centeredness to real practice. Realizing the immense potential of medical cannabis requires the entire industry to finally attain the guidance needed to manage individual patients.
Yael Richter, Ph. D
Chief Scientific Officer (CSO)
The success of innovative technology is highly dependent on humans to engage with the technology and exchange data. Only together, by sharing information, can we ensure the promotion of a healthcare environment that will indeed benefit all.
Yaron Gissin
Co-Founder, Chief Innovation Officer
BLOG
0
Current Onboarded ASAYA Patients
0 M
Cumulative of number Patient-based Data Points
+ 0
Patients Registered in Clinical Trials
$ 0
Average Medical Cannabis Spend Per Patient/Year

Please join our ever-growing group of early adaptors. If you are a medical cannabis patient, user, healthcare provider, researcher or fan – and have information to share with the world: please click below, fill in brief info and join our journey.